Gill's Process Control joins Efor, strengthening our CQV presence in the United States

North Carolina has become one of the most dynamic pharmaceutical and biotechnology hubs in the United States. In a market defined by tight timelines, high compliance expectations, and complex facilities, delivery is won on the ground — with strong local teams and proven methods. This is exactly where Gill’s Process Control joining Efor makes a difference.

Founded in 1995 and based in Rocky Mount, North Carolina, Gill’s Process Control (GPCi) is recognized for its expertise in Commissioning, Qualification & Validation (CQV) for the pharmaceutical and biotechnology industries. With nearly 30 years of experience, the company supports manufacturers in qualifying their equipment, systems, and facilities, and in bringing their production environments into compliance.

A major step for Efor in the US

Since establishing its presence in Boston in 2023, Efor has made the United States a strategic priority of its international development. Following the integration of DynamixE earlier this year, the addition of Gill’s Process Control confirms the pace of that North American development: it consolidates the Group’s U.S. platform and reinforces an already-established footprint in North Carolina, one of the country’s leading pharmaceutical and biotechnology hubs.

Stronger support on complex industrial projects

On high-complexity programs, impact comes down to very concrete capabilities:

• proven, field-based CQV expertise built on real production environments;
• a deep understanding of U.S. regulatory requirements and delivery standards;
• delivery continuity on critical programs, at the level of quality and compliance the life sciences demand.

A natural alignment

The integration rests on strong operational alignment: the same CQV core business, the same quality standards, and the same belief that the proximity of a local player, combined with the resources of an international group, is the best answer to the most strategic projects. This step supports Efor’s ambition to consolidate a still-fragmented market and build the global leader in quality and compliance for the life sciences industry.

If you run industrial projects in North Carolina or elsewhere in the United States and face CQV and compliance challenges, our teams can share a field-based perspective on the approach and the key success factors.